The Valley Desk

NCT02326272 · Interventional trial

A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Overall registry status Completed

Phase 3

Conditions Plaque Psoriasis, Psoriasis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov